Related by context. All words. (Click for frequent words.) 69 Gastrointestinal Oncology 68 Bone Metastases 68 Metabolic Disease 67 Autoimmune Diseases 66 Hematologic Malignancies 66 Neurodegenerative Disease 65 Successfully Treats 65 Hormone Refractory Prostate Cancer 65 Inflammatory Diseases 65 REMINDER ORLive Presents 65 Advanced Melanoma 65 Cardiovascular Imaging 64 Drug Shows Promise 64 Stem Cell Transplant 64 Investigational Treatment 64 Synthetic Peptide 64 Islet Transplantation 64 Shows Promise Against 64 Cancer Treatments 64 Phase 2b Clinical Trial 64 Completes Patient Enrollment 64 Maven Semantic 64 Acute Pain 63 Autologous Stem Cell Transplantation 63 Diabetic Foot Ulcer 63 Nuclear Receptors 63 Severe Sepsis 63 Patient Enrollment 63 Clinical Outcome 63 Cancer Immunotherapy 63 Inflammatory Disease 63 Embolization 63 Announces FDA Clearance 63 Nat Rev 63 Protein Expression 63 Minimally Invasive Treatment 63 Mitral Valve Repair 63 Develop Novel 63 Adenoma 63 Improves Outcomes 63 Clinical Trial Results 63 Prenatal Diagnosis 63 Clinical Outcomes 63 Drug Prevents 63 Therapeutic Antibody 63 Completes Enrollment 63 Liver Cancer 63 Initiates Enrollment 63 Effectively Treats 63 Receives Orphan Drug Designation 63 Initiates Clinical Trial 63 Prolongs Survival 63 Study Evaluating 63 Lipid Metabolism 62 Phase III Trial 62 Osteoporosis Treatment 62 Hormone Receptor Positive 62 Files IND 62 Initiates Phase III 62 Lung Tumors 62 Regenerative Cells 62 Endocrinol 62 Circulating Tumor Cells 62 Teva Provides Update 62 See CLINICAL PHARMACOLOGY 62 Non Invasive 62 Mouse Models 62 Oral Calcitonin 62 Dupuytren Disease 62 Successfully Treated 62 Stomach Cancer 62 Pediatric Rheumatology 62 Heart Failure Patients 62 Complicated Skin 62 Cancer Patients Treated 62 Meets Primary Endpoint 62 Adjuvant Chemotherapy 62 Slows Progression 62 Molecular Virology 62 Phase 2b Trial 62 Molecular Basis 62 Treating Chronic 62 Anticancer Drug 62 M.D. Ph.D. 62 Receives FDA Clearance 62 Vaccine Adjuvant 62 ORLive Presents 62 Breast Cancer Recurrence 62 Medical Research Katholic 62 Bone Marrow Transplantation 62 Protein Biomarker 62 Novel Oral 62 Oral Fingolimod 62 Metastatic Melanoma 62 Commercialize Novel 62 Female Urology 61 Endothelial Cells 61 Clinical Proteomics 61 Biomarker Discovery 61 Integrative Neuroscience 61 Appears Safe 61 Renal Artery 61 Initiates Phase II 61 HER2 Positive 61 Recombinant Protein 61 Gene Mutation 61 Vaccine Shows Promise 61 Toenail Fungus 61 ST Elevation Myocardial 61 Enlarged Prostate 61 Small Molecule 61 Cardiac Arrhythmia 61 Breast Cancer Cells 61 Myelodysplastic Syndromes 61 Magnetic Nanoparticles 61 Pulmonary Hypertension 61 Author Affiliations 61 Reperfusion Injury 61 Hematology Molecular Pathology 61 Initiate Clinical Trial 61 Minimally Invasive Procedure 61 Demonstrates Efficacy 61 FDA Clears 61 Soft Tissue Sarcoma 61 Expression Profiling 61 Nicotine Vaccine 61 Improves Survival 61 Contrast Agent 61 Inflammatory Markers 61 Enrolling Patients 61 Transdermal Patch 61 Treatment Shows Promise 61 Test Detects 61 Patients Treated With 61 Novel Treatments 61 Bladder Cancer 61 Neuromuscular Disease 61 FDA Approves Drug 61 Demonstrates Sustained 61 Protein Linked 61 FDA Approvals 61 Microwave Ablation System 61 Treatment Reduces 61 Unfractionated Heparin 61 Launches Generic Version 61 Less Invasive 61 Stereotactic Radiosurgery 61 Neurodegenerative Disorders 61 Patients Undergoing 61 Crit Rev 61 Stem Cell Transplants 61 Acute Stroke 61 Vitrasert R 61 Reduces Mortality 61 Study Shows Promise 61 Renal Cell Carcinoma 61 Initiate Phase III 61 Circulatory Support 61 Gastric Cancer 60 Arthritis Musculoskeletal 60 Pulmonary Arterial Hypertension 60 J Am Coll 60 Presents Preclinical Data 60 Adjuvant Treatment 60 Preclinical Study 60 Cell Transplant 60 Investigational Drug 60 Vascular Medicine 60 Functional Neurosurgery 60 Chemoprevention 60 Interstitial Lung Disease 60 Study Showed 60 Novel Therapeutics 60 Lowers Risk 60 Radiation Treatment 60 Clin J 60 Oncologic 60 Drug Combo 60 Image Guided 60 Randomized Study 60 Genes Involved 60 M.D. 60 Early Diagnosis 60 Clinical Efficacy 60 Hormone Replacement 60 Antiplatelet Therapy 60 Spinal Fusion 60 Lankenau Institute 60 Treatment Resistant 60 Metabolic Diseases 60 SIX RO ROG 60 Molecular Diagnostic Test 60 Overactive Bladder 60 Licenses Novel 60 Carcinomas 60 Male Contraceptive 60 Catheter Ablation 60 Therapy Evaluation 60 Oral Cladribine 60 TRANSDUR ® 60 Kidney Transplant Patients 60 Renal Cancer 60 Investigational Compound 60 Immunotherapeutic 60 Recurrent Breast Cancer 60 Extracellular Matrix 60 Tissue Engineered 60 Bone Marrow Transplants 60 Significantly Improves 60 Breast Cancer Treatment 60 Radiofrequency Ablation 60 pralatrexate injection folate analogue 60 Vascular Disease 60 Current Author Addresses 60 Chronic Sinusitis 60 Urologic Cancer 60 Prognostic Value 60 Preclinical Development 60 Acute Treatment 60 Diagnostic Tests 60 Peripheral Arterial 60 NAVISTAR R 60 Cardiac Stem Cell 60 Blood Vessels 60 Regenerative Cell 60 Advanced Heart Failure 60 Therapeutic Angiogenesis 60 Nerve Regeneration 60 Preclinical Data 60 Tumor Microenvironment 60 Combination Treatment 60 Genes Predict 60 Mylan Receives Approval 60 Medical Oncologist 60 Proves Effective 60 Cardiac Imaging 60 Shows Efficacy 60 Cardiac Catheterization Laboratories 60 Neuroendocrine 60 Combination REOLYSIN R 60 Pediatric Cardiac 60 Stem Cell Treatment 60 Therapeutic Vaccines 60 Migraine Treatment 60 Breast Cancer Patients 60 Gets FDA Clearance 60 Mimetics 60 Venous Thrombosis 60 Eluting Stent 60 Autoimmune Disease 60 Anti Tumor 60 Immune Cell 60 Severe Asthma 60 Treating Prostate Cancer 60 Multicenter Randomized 60 Postmenopausal Women 60 Immunol 60 Initiates Phase 2b 60 Genes Identified 60 Study Demonstrates 60 Liver Metastases 60 Laryngeal Cancer 59 Experimental Therapeutics Program 59 Aneurysm Repair 59 Phase III Clinical Trial 59 Cancer Stem Cells 59 First Patient Enrolled 59 Cancer Incidence Mortality 59 Drug Candidate 59 Prostate Biopsy 59 Molecular Cardiology 59 Refractory Angina 59 Contrast Enhanced 59 Cerebrospinal Fluid 59 Left Ventricular Hypertrophy 59 Phase III Pivotal 59 RNAi Therapeutic 59 Renal Anemia 59 Male Infertility 59 Founding Scientist 59 Tumor Biology 59 Diabetic Patients 59 Endothelial 59 Hematological Malignancies 59 Improve Survival 59 Cutaneous T 59 Solid Malignancies 59 Solid Tumor 59 Hyperlipidemia 59 Berlin Buch Germany 59 ST Segment Elevation 59 Analytical Tool 59 Combination Therapy 59 Helps Predict 59 Develops Novel 59 Pediatric Asthma 59 Developmental Therapeutics 59 AIR2 Trial 59 Clinical Trial Evaluating 59 Osteoporosis Drug 59 Anthrax Toxin 59 Alternative Treatments 59 HCV Protease Inhibitor 59 Mouse Model 59 CYT# potent vascular disrupting 59 Initiates Clinical 59 Spinal Disc 59 Hormone Therapy 59 Naive Patients 59 Randomized Double Blind 59 Author Affiliation 59 Targeted Therapy 59 platform HDL Mimetic 59 Antitumor Activity 59 Thrombotic 59 Pharmaceuticals Initiates 59 Curr Opin 59 Disease IBD 59 Treatment Naive Patients 59 Cancer Therapeutic 59 Quantitation 59 Slow Progression 59 Cardiotoxicity 59 Tumor Response 59 Neurosurgical Products 59 Breast Cancer Metastasis 59 Ultrasensitive 59 Alvine Pharmaceuticals 59 kidney urologic 59 Brain Metastases 59 Viral Infection 59 Node Positive 59 Bucindolol 59 Anticancer Agent 59 FDA Okays 59 Lung Cancer Patients 59 Biomarker Study 59 Dose Response 59 Bioartificial Liver 59 Inflammatory Arthritis 59 Advanced Colorectal Cancer 59 Patients Receiving 59 Therapeutic Efficacy 59 Diabetes Endocrinology 59 Universitätsklinikum 59 Hepatocellular 59 Malignant Melanoma 59 Intravesical 59 R lenalidomide 59 Demonstrates Positive 59 Researchers Identify 59 Cytotoxicity 59 Lymph Node 59 Monoclonal Antibody 59 Rheumatoid Arthritis Patients 59 Bad Krozingen Germany 59 Prostate Cancer Treatment 59 Neuro oncology 59 Pediatric Endocrinology 59 Xenografts 59 Antigen Specific 59 Transplant Patients 59 Ovarian Cancer Patients 59 Anticoagulation 59 Vaccine Adjuvants 59 Refractory Hodgkin Lymphoma 59 Prolongs Life 59 Tyrosine Kinase Inhibitor 59 Advanced Renal Cell 59 Anthracycline 59 MD PhD Professor 59 Successfully Completes Phase 59 Chronic Myeloid Leukemia 59 Atopic Dermatitis 59 Prospective Randomized 59 Hematopoietic Stem Cell Transplantation 59 Hemostasis 59 Reduces Risk 59 allogeneic hematopoietic stem cell 59 Postdoctoral Position 59 Heart Transplantation 59 Castration Resistant Prostate Cancer 59 Tumor Growth 59 Blood Cancers 59 Multicenter Trial 59 Genetic Disorders 59 First Patient Dosed 59 Arterial Disease 59 Allograft 59 Squamous Cell Carcinoma 59 Breast Tumors 59 Gene Linked 59 Acute Myocardial Infarction 59 Organ Rejection 59 Virus Linked 59 Protein Microarray 59 migraines neurorehabilitation 59 Multiple Myeloma Patients 59 TRANSDUR ™ 59 Hepatic Encephalopathy 59 Neck Cancers 59 Lung Injury 59 Therapy Shows Promise 59 Liver Tumors 59 Shown Effective 59 Immunosuppressant 59 Bazedoxifene 59 Eur J 59 Carotid Stenting 59 Breast Oncology 59 Novel Therapeutic 59 Phase IIb Clinical Trial 59 lexidronam injection 59 Breast Brachytherapy 59 Drug Fails 58 Artery Disease 58 Kidney Transplantation 58 Dosimetry 58 Shows Promising 58 Gene Mutations 58 Inhaled Corticosteroids 58 Anti Tumor Activity 58 Neurovirology 58 Neurodegenerative Diseases 58 Plaque Psoriasis 58 CT Angiography 58 Hematologist 58 Cancer Vaccines 58 Novel Vaccine 58 Rheumatoid 58 Non Invasive Treatment 58 Hernia Repair 58 Neoplasms 58 Hemodialysis Patients 58 Esophageal 58 Phase Ib Clinical Trial 58 Tacrolimus 58 Neuroendocrine Tumor 58 Anticancer Activity 58 Blood Pressure Drug 58 Attenuates 58 Phase 2a Clinical Trial 58 Receives Milestone Payment 58 Cognitive Deficits 58 Principle Investigator 58 Lung Cancer Drug 58 Antibody Discovery 58 Stereotactic Body Radiation Therapy 58 Antipsychotic Drug 58 Immune Responses 58 Pediatric Bone Marrow 58 #:#-# [007] 58 Radiosurgery 58 Novel Method 58 Photomedicine 58 Premenopausal Women 58 Genetic Markers 58 Cartilage Repair 58 Sentinel Lymph Node 58 Hospitalized Patients 58 Myelodysplastic Syndrome 58 Genitourinary 58 Hepatocellular Carcinoma 58 Prostatic 58 First Patient Treated 58 Gynecologic 58 Basic Biomedical Sciences 58 ovarian pancreatic 58 Drug Resistant 58 Zilver PTX Drug Eluting 58 Surgical Treatment 58 Antibody Drug Conjugate 58 Human Neural Stem 58 Pediatric Patients 58 Therapeutic Targets 58 Resistant Hypertension 58 Genes Linked 58 Contrast Agents 58 Previously Untreated 58 Delcath Phase III 58 Molecular Pathology 58 molecular imaging radiopharmaceutical 58 J Am Acad 58 Developmental Genetics 58 Lung Cancer Survival 58 Phenotyping 58 Myocardial Ischemia 58 Novel Inhibitor 58 Pivotal Phase III 58 Drug Eluting 58 Relapsed Refractory 58 Malignancies 58 Present Preclinical Data 58 Dendritic Cells 58 Smooth Muscle 58 Drug Eluting Coronary Stent 58 Subgroup Analysis 58 Transplant Rejection 58 Fungal Infections 58 Hepatitis C Genotype 58 Neurotherapeutics 58 Innate Immune 58 Generic Version 58 Anti Angiogenesis 58 Lumbar Spine 58 zoledronic acid Reclast 58 Brain Disorders 58 Cholesterol Drug 58 Clinical Evaluation 58 Esophageal Cancer 58 Initiates Dosing 58 Chronic Heart Failure 58 Multiple Sclerosis Rheumatoid Arthritis 58 Neuroendocrine Tumors 58 Carboplatin Paclitaxel 58 HER2 Positive Breast Cancer 58 Molecular Mechanism 58 Cardiac Electrophysiology 58 MassGeneral Institute 58 Implantable Device 58 Pharma Merck Serono 58 Oral Mucositis 58 Cell Differentiation 58 Anti Angiogenic 58 Presents Positive 58 MD FACG 58 Glaucoma Treatment 58 Systemic Sclerosis 58 Mechanical Circulatory Support 58 Reduces Pain 58 developing Bicifadine serotonin 58 Submits NDA 58 Transcatheter 58 Lung Cancer Trial 58 Basal Cell 58 Epilepsy Drug 58 Bosutinib 58 Breast Ultrasound 58 Interventional Neuroradiology 58 Fondaparinux 58 Advanced Prostate Cancer 58 Knee Osteoarthritis 58 Neoadjuvant Chemotherapy 58 Cardiol 58 Treatment Naïve Patients 58 Hypertensive Patients 58 PhD MGH 58 Neck Oncology 58 siRNA Delivery 58 Advanced Ovarian Cancer 58 Intravascular 58 Treat Anemia 58 Antithrombin 58 Acute Heart Failure 58 Cervical Dysplasia 58 Balloon Angioplasty 58 Microvascular 58 Parathyroid Hormone 58 Prospective Multicenter 58 Breast Cancers 58 Subtypes 58 Phase 2a Trial 58 Limb Ischemia 58 Address reprint requests 58 Metastatic Colorectal Cancer 58 Lymphoid 58 Kidney Failure 58 J Clin 58 Oncolytic Reovirus 58 Prophylactic Treatment 58 Pulmonary Allergy 58 Previously Treated 58 Randomized Clinical Trial 58 Endovascular Treatment 58 Tezampanel 58 Patients Treated 58 Urinary Incontinence 58 NDA Submission 58 Aortic Valve Replacement 58 Unstable Angina 58 Pooled Analysis 58 Breast Tumor 58 Novel Therapies 58 Metastatic Disease 58 Viral Infections 58 Thrombophilia 58 Infected Patients 58 Bisphosphonate 58 Neurodegenerative 58 MEK Inhibitor 58 Rectal Cancer 58 Mg Uk 58 Chronic Hepatitis C 58 Pre Cancerous 58 Dermatopathology 58 Statin Therapy 58 FDA Accepts 58 Autoantibodies 58 Molecular Carcinogenesis 58 Randomized Trials 58 Liprotamase 58 Cytometry 58 Polymerase Inhibitor 58 Respiratory Virus 57 Heart Transplant Recipients 57 Shows Statistically Significant 57 Metastases 57 Neuro Oncology Program 57 C1 Inhibitor 57 Chronic HCV 57 Pain Therapy 57 Patients Suffering 57 Atherosclerosis Research 57 Pivotal Trial 57 Effective Treatments 57 Liver Disease 57 Survival Benefit 57 Improve Outcomes 57 Ovarian Cancers 57 #-# Full Text 57 Winship Cancer Institute 57 MD FACC FACP 57 Diabetic Neuropathy 57 Genomic Analysis 57 aneurysms AAA 57 Induction Therapy 57 Cell Transplants 57 Immune Cells 57 Treat Heart Failure 57 Peginterferon Alfa 2a 57 Shows Promise 57 Cardiac Arrhythmia Service 57 Excessive Sweating 57 Neuroprotection 57 Epidemiological Studies Unit 57 RNAi Therapeutics 57 Prognostic Factors 57 Neck Cancer 57 Trial Evaluating 57 Immunobiology 57 Study Validates 57 MD MHSc 57 Benign Prostatic Hyperplasia 57 Meta Analysis 57 Molecular Mechanisms 57 Antibiotic Resistant 57 Vaccine Trials 57 Awarded Qualifying Therapeutic 57 Artificial Pancreas 57 Pulmonary Critical Care 57 Submits Biologics License Application 57 recurrent metastatic ovarian cancer 57 Hypertrophy 57 Psoriasis Drug 57 Vascular Diseases 57 Surgical Mesh 57 Relapsing Multiple Sclerosis 57 Cardiac Catheterization Laboratory 57 Sangamo BioSciences Announces 57 Levels Linked 57 INSPIRE Trial Phase III 57 Immunologic 57 Parathyroid 57 #:#-# [024] 57 Thromboembolic 57 Author Affiliations Division 57 Clinical Trial 57 Muscle Function 57 Osteoarthritis Patients 57 deCODE ProstateCancer TM 57 Asthma Treatment 57 Urologic Oncology 57 Tjeerdema chairs 57 Expanded Indication 57 Atypical Hemolytic Uremic Syndrome 57 Vitro Activity 57 Long Term Efficacy 57 Receives Approvable Letter 57 Acute Liver Failure 57 Pathology Informatics 57 Cancer Diagnosis 57 Receives Marketing Authorization 57 Transdermal Delivery 57 Screenings Offered 57 Aortic Valve 57 Asthma COPD 57 Therapeutic Competitors Report 57 Orthop Surg 57 Anti Infective 57 Interferon Alpha 57 Neurological Diseases 57 Neoadjuvant 57 Inhaled Nitric Oxide 57 Pancreatic 57 Gout Drug 57 Spinal Fluid 57 Vascular Inflammation 57 Wrinkle Treatment 57 Ph.D. D.Sc. 57 Primary Immunodeficiencies 57 Stress Induced 57 Risk Stratification 57 Vertebral Fractures 57 Leukemias 57 Photodynamic Therapy 57 Ventricular Arrhythmias 57 Clinical Study 57 Cardiac Rhythm 57 Epiphany Biosciences 57 Pituitary 57 Therapeutic Potential 57 Oral Cavity 57 Allergic Diseases 57 Helps Smokers Quit 57 Venous Thromboembolism 57 Inhaled Liposomal Ciprofloxacin 57 Antiangiogenic 57 Adjuvant Therapy 57 acetonide FA 57 topically applied SEPA 57 Reduced Risk 57 Prenatal Screening 57 Cancer Immunotherapeutics 57 Safinamide 57 Invasive Breast Cancer 57 AVI BioPharma Announces 57 Biostatistician 57 essential thrombocythemia ET 57 Anticoagulant 57 Prove Effective 57 Fondazione IRCCS Istituto Nazionale 57 Desvenlafaxine Succinate 57 Transplantation Surgery 57 Emerging Therapies 57 NewYork-Presbyterian/Weill Cornell 57 Mitral Regurgitation 57 Oral Presentations 57 Therapy Improves 57 Targeted Therapies 57 Announce License Agreement 57 Peripheral Blood 57 Progenitor Cells 57 Estrogen Therapy 57 NIMH Mood 57 Gum Disease 57 TB Vaccine 57 Virtual Colonoscopy 57 Coronary Angiography 57 Cellular Immunology 57 Announces Tentative Approval 57 Demonstrates Potent 57 Postherpetic Neuralgia 57 Metabolic Endocrinology 57 Seasonal Influenza Vaccine 57 Diabetic Ulcers 57 Accessed #/#/# [001] 57 Cardiovascular Disease Prevention 57 Anal Cancer 57 Tyrosine Kinase Inhibitors 57 Schizophrenia Treatment 57 Paediatr 57 Lung Cancers 57 Demonstrates Significant 57 Cardiac Catheterization 57 Epidermal Growth Factor Receptor 57 ALN HPN 57 Submits Supplemental 57 Desvenlafaxine 57 Bone Marrow Cells 57 Valve Replacement 57 Topical Treatment 57 Tissue Regeneration 57 Rheumatoid Arthritis Drug 57 pharmacogenomic translational research 57 Neurobiology Laboratory 57 Drug Metabolism 57 Metabolic Bone Diseases 57 Coronary Arteries 57 Replacement Therapy 57 Int J 57 Protease Inhibitor 57 Brain Tumors 57 Intravitreal 57 Treating Depression 57 Cholesterol Levels SPARCL 57 Protein Involved 57 Reports Preclinical Data 57 Schizophrenia Drug 57 Helps Diagnose 57 MR Angiography 57 Arthritis Drug 57 Bleeding Disorder 57 hyaluronidase enzyme 57 Total Knee Arthroplasty 57 Simulect 57 Acute Exacerbations 57 Cutaneous Oncology 57 Modulates 57 Muscle Wasting 57 Epstein Barr Virus EBV 57 Surgery Urology 57 Optical Sensors 57 Immune Mediated 57 Cancer Therapies 57 Musculoskeletal Diseases 57 Renal Function 57 Deutsches Herzzentrum 57 Aggressive Prostate Cancer 57 Kidney Transplant Recipients 57 Flow Cytometry 57 Companion Diagnostic 57 Immune Disease 57 Preclinical Models 57 Predict Prostate Cancer 57 Retrovirus 57 J Cataract Refract 57 ScD MPH 57 Tumor Immunology 57 Controlled Study 57 Coronary Interventions 57 Cholesterol Lowering Drug 57 Leukemia Lymphoma 57 Disease Modifying 57 Personalized Immunotherapy 57 Hematologic Oncology 57 MD M.Sc. 57 Augment TM 57 Lupus Drug 57 Molecular Genetics Laboratory 57 Cardiac Resynchronization 57 Tissue Repair 57 Kinase Inhibitor 57 Beta Blockers 56 Pancreatic Adenocarcinoma 56 Single Incision 56 Molecular Pharmacology 56 Stent Thrombosis 56 JAK2 Inhibitor 56 Receives CE Marking 56 Autologous 56 Therapy Reduces 56 Hsp# Inhibitor 56 Chemotherapeutic Agents 56 Insulin Resistance 56 Translational Biology 56 Develop Innovative 56 OHSU Cancer 56 J.P. Morgan Healthcare 56 Breast Density 56 Earns Milestone Payment 56 Colorectal Cancers 56 Newly Diagnosed Breast Cancer 56 J Shoulder Elbow 56 Clinical Trials Consortium 56 Hepatitis C Virus 56 Pediatric Brain Tumors 56 Max Delbrueck Center 56 Cardiovasc 56 Membrane Proteins 56 Genetics Laboratory 56 dasatinib Sprycel ® 56 High Throughput Biology 56 ERBE GmbH 56 Islet Transplant 56 Inhibits Growth 56 Pregnancy Outcomes 56 Gentium Announces 56 Inflammatory Response 56 #:#-# [023] 56 Computational Genomics 56 Molecular Diagnostic 56 DNA Methylation 56 IND Application 56 Post Operative 56 Myeloma Patients 56 Antisense Drug 56 Researchers Uncover 56 Cypher Sirolimus 56 Cancer Survivorship Program 56 Is Well Tolerated 56 Myoblast 56 Elderly Patients 56 Predict Breast Cancer 56 Pancreas Cancer 56 Hematopoietic 56 Antiplatelet 56 Boehringer Ingelheim MedImmune 56 Pancreas Transplant 56 TIMI Study Group 56 Pancreatic Cancer 56 Files Patent Application 56 Childhood Asthma 56 Metabolic Medicine 56 Minimally Invasive Therapy 56 Disease Causing 56 Randomized Phase III 56 Infect Dis 56 Unresectable 56 Cancer Metastasis 56 Valvular Heart Disease 56 Kinase Inhibitors 56 Sapacitabine 56 Adjunctive Therapy 56 Urogynecology 56 Well Tolerated 56 Epithelial Cell 56 Microbial Pathogenesis Seminar 56 Ureteral 56 Advanced Solid Tumors 56 Vascular Grafts 56 Stem Cell Differentiation 56 Cancer Cells 56 External Fixation 56 Glatiramer Acetate 56 Lung Transplant Program 56 Thoracic Oncology Program 56 Telik Announces 56 Unstable Angina Non 56 Cognitive Disorders 56 Cell Signaling 56 Hormone Receptor 56 Mohs Micrographic Surgery 56 Single Dose 56 Obese Patients 56 Chronic Lymphocytic Leukemia CLL 56 thalidomide Thalomid 56 Confocal Microscopy 56 Acute Renal Failure 56 Bone Fractures 56 Microbial Pathogenesis 56 External Beam 56 Hepatitis C Virus HCV 56 Merck Serono Nycomed 56 Blood Vessel 56 Copegus ® 56 Brain Tumor Patients 56 Intravenous Formulation 56 Hematologic 56 Marillion Pharmaceuticals 56 Endurant 56 Laser Ablation 56 Fibrin Sealant 56 Renal Cell Cancer 56 Gertrude H. Sergievsky 56 Chemoradiation 56 Vascular Targeting Agents 56 By Kathleen Doheny 56 Annu Rev 56 Kidney Function 56 PRN FDA Approves 56 Gene Variant 56 Inhibits 56 PhD RPh 56 Immunogenetics 56 Biotyper 56 Cancer Biology 56 MD Ph. D. 56 Radiopharmaceutical 56 Toxicogenomics 56 INGAP 56 Roche Boniva 56 Glickman Urological 56 Diagnostic Criteria 56 Lipid Lowering 56 Gene Silencing 56 Thyroid Cancer 56 Newly Diagnosed Patients 56 Recombinant Human 56 PharmD MPH 56 Differential Diagnosis 56 Pneumococcal Vaccine 56 Bone Marrow Stem Cell 56 Hematopathology 56 Lanthanum Carbonate 56 Biol Phys 56 Abstract Accepted 56 Molecular Evolution 56 Initiate Phase 56 Bipolar Disorders 56 Chronic Renal Failure 56 Antibody Therapeutics 56 Demonstrates Potential 56 Genetic Predisposition 56 Vaccine Protects Against 56 Proven Effective 56 Extracorporeal Shock Wave 56 Device Helps 56 Endotoxin Activity Assay 56 Aggressive Reduction 56 evaluating picoplatin 56 Chronic Lymphocytic Leukemia 56 Iron Overload 56 Investigational Agent 56 Acute Ischemic Stroke 56 Observational Study 56 Holds Promise 56 Visceral Fat 56 Skin Cancers 56 Secondary Hyperparathyroidism